BSECompany Update6d ago · 14 Aug 2026, 12:01 pm

Please find enclosed herewith the copies of newspaper advertisement published regarding the extract of statement of Un-audited Standalone and Consolidated Financial Results of the Company ....

Bliss GVS Pharma Ltd · 506197

✦ AI SummaryResults

Bliss GVS Pharma Ltd has published the un-audited standalone and consolidated financial results for the quarter ended June 30, 2026, in accordance with Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Analysis Scores

Earnings Impact5/10
Growth Catalyst5/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk5/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Bliss GVS Pharma Ltd - 506197 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Attachments (1)

📄

de723762-78e9-45d6-986f-90f0e490fbee.pdf

pdf

Download →
View document text
August 14, 2026 To To The Manager, Listing Department The General Manager, Listing Department National Stock Exchange of India Limited BSE Limited Plot no. C/1 G Block, Phiroze Jeejeebhoy Towers, Bandra-Kurla Complex, Bandra (East), Dalal Street, Mumbai- 400 051 Mumbai- 400 001 Symbol: BLISSGVS Scrip Code: 506197 Dear Sir/Madam, Subject: Intimation of publication of Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026 According to the provision of Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the copies of the newspaper advertisement published regarding the extract of the statement of un-audited standalone and consolidated financial results for the quarter ended June 30, 2026, along with the Quick Response Code (“QR Code”) and weblink of the Company to access complete Financial Results in ‘The Economic Times & The Free Press Journal’ an English Daily and ‘Maharashtra Times & Navshakti’ a Regional Daily, on August 14, 2026. Kindly take the same on record. Thanking you. Yours faithfully, For Bliss GVS Pharma Limited Aditi Bhatt Company Secretary Encl: as above